<!DOCTYPE html>

<html lang="en" data-theme="light">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Corticosteroids - Essentials of Medical Pharmacology</title>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link
        href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap"
        rel="stylesheet">

    <link rel="stylesheet" href="../styles/main.css">

    <script>
        MathJax = {
            tex: {
                inlineMath: [['$', '$'], ['\\(', '\\)']],
                displayMath: [['$$', '$$'], ['\\[', '\\]']],
                processEscapes: true,
                processEnvironments: true
            },
            svg: { fontCache: 'global' },
            options: {
                skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
            }
        };
    </script>

    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>

</head>

<body>
    <a href="#main-content" class="skip-link">Skip to main content</a>

    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <div class="reading-progress-container">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <!-- Floating TOC -->

    <nav class="floating-toc" id="floating-toc">
        <div class="floating-toc-header">
            <span>üìë</span> Table of Contents
        </div>
        <ul class="floating-toc-list">
            <li><a href="#introduction">Biosynthesis & Regulation</a></li>
            <li><a href="#mineralocorticoids">Mineralocorticoids</a></li>
            <li><a href="#glucocorticoids">Glucocorticoids: Actions</a></li>
            <li><a href="#mechanism">Mechanism of Action</a></li>
            <li><a href="#preparations">Preparations & Potency</a></li>
            <li><a href="#uses">Therapeutic Uses</a></li>
            <li><a href="#adverse-effects">Adverse Effects</a></li>
            <li><a href="#withdrawal">HPA Suppression & Withdrawal</a></li>
            <li><a href="#inhibitors">Inhibitors</a></li>
            <li><a href="#case-study">Problem Directed Study</a></li>
        </ul>
    </nav>

    <div class="page-wrapper">
        <div class="container">
            <article class="document-article">
                <header class="document-header">
                    <div class="header-badge">
                        <span>üíä</span>
                        <span>Topic 21</span>
                    </div>
                    <h1 class="document-title">Corticosteroids</h1>
                    <div class="title-meta">
                        <div class="meta-item">
                            <span>üìö</span>
                            <span>Hormones and Related Drugs</span>
                        </div>
                        <div class="meta-item">
                            <span>‚è±Ô∏è</span>
                            <span>55 min read</span>
                        </div>
                    </div>
                </header>
                <main id="main-content" class="content-wrapper">
                    <!-- Section 1: Biosynthesis -->
                    <section class="content-section" id="introduction">
                        <div class="section-header">
                            <div class="section-number">01</div>
                            <h2 class="section-title">
                                <span class="title-icon">üß¨</span>
                                Biosynthesis & Regulation
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>The adrenal cortex secretes steroidal hormones which have glucocorticoid,
                                mineralocorticoid and weakly androgenic activities. They are synthesized from
                                cholesterol. The secretion is controlled by ACTH from the pituitary, which in turn is
                                regulated by CRH from the hypothalamus and negative feedback by circulating corticoids
                                (Hypothalamo-Pituitary-Adrenal or HPA axis).</p>
                            <p><strong>Daily Secretion:</strong></p>
                            <ul>
                                <li><strong>Hydrocortisone (Cortisol):</strong> 10-20 mg daily (circadian rhythm: peak
                                    in morning).</li>
                                <li><strong>Aldosterone:</strong> 0.125 mg daily.</li>
                            </ul>
                        </div>
                    </section>

                    <!-- Section 2: Mineralocorticoids -->
                    <section class="content-section" id="mineralocorticoids">
                        <div class="section-header">
                            <div class="section-number">02</div>
                            <h2 class="section-title">
                                <span class="title-icon">üßÇ</span>
                                Mineralocorticoid Actions
                            </h2>
                        </div>

                        <div class="content-card">
                            <p><strong>Aldosterone</strong> is the principal mineralocorticoid.</p>
                            <ul class="enhanced-list">
                                <li class="list-item"><strong>Action:</strong> Enhances $Na^+$ reabsorption from the
                                    distal convoluted tubule in kidney, associated with increased $K^+$ and $H^+$
                                    excretion.</li>
                                <li class="list-item"><strong>Mechanism:</strong> Gene mediated increased transcription
                                    of mRNA synthesis of <strong>Aldosterone Induced Proteins (AIP)</strong> like
                                    $Na^+K^+$-ATPase and epithelial $Na^+$ channels (ENaC).</li>
                                <li class="list-item"><strong>Result:</strong> Salt and water retention, expansion of
                                    ECF volume, hypertension, hypokalemia, alkalosis.</li>
                            </ul>
                        </div>
                    </section>

                    <!-- Section 3: Glucocorticoids Actions -->
                    <section class="content-section" id="glucocorticoids">
                        <div class="section-header">
                            <div class="section-number">03</div>
                            <h2 class="section-title">
                                <span class="title-icon">‚ö°</span>
                                Glucocorticoid Actions
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Glucocorticoids have widespread permissive and direct actions, preparing the body to
                                withstand stress.</p>

                            <div class="grid grid-2">
                                <div class="grid-item">
                                    <h4>Metabolic Effects</h4>
                                    <ul>
                                        <li><strong>Carbohydrate:</strong> Promotes gluconeogenesis, glycogen
                                            deposition, inhibits peripheral glucose utilization $\rightarrow$
                                            <strong>Hyperglycaemia</strong> (Diabetogenic).
                                        </li>
                                        <li><strong>Protein:</strong> Catabolic. Muscle wasting, negative nitrogen
                                            balance.</li>
                                        <li><strong>Fat:</strong> Redistribution of fat (Moon face, buffalo hump).
                                            Permissive for lipolysis.</li>
                                    </ul>
                                </div>
                                <div class="grid-item">
                                    <h4>Systemic Effects</h4>
                                    <ul>
                                        <li><strong>CVS:</strong> Maintains vascular tone (permissive for
                                            catecholamines). Restricts capillary permeability.</li>
                                        <li><strong>Muscle:</strong> Maintains contractility (weakness occurs in
                                            deficiency).</li>
                                        <li><strong>CNS:</strong> Mild euphoria, lowers seizure threshold.</li>
                                        <li><strong>Stomach:</strong> Increases acid/pepsin (ulcerogenic).</li>
                                    </ul>
                                </div>
                            </div>

                            <h3>Anti-inflammatory & Immunosuppressive Actions</h3>
                            <p>This is the basis for most clinical uses.</p>
                            <ul class="enhanced-list">
                                <li class="list-item"><strong>Suppression of Inflammation:</strong> Inhibits all stages
                                    (redness, heat, swelling, pain). Inhibits recruitment of leukocytes, suppresses
                                    production of PGs and Leukotrienes (by inducing <strong>Annexins/Lipocortin</strong>
                                    which inhibit Phospholipase A2).</li>
                                <li class="list-item"><strong>Immunosuppression:</strong> Suppresses cell-mediated
                                    immunity (T-cells more sensitive). Suppresses graft rejection and delayed
                                    hypersensitivity.</li>
                                <li class="list-item"><strong>Lympholysis:</strong> Destroys malignant lymphoid cells.
                                </li>
                            </ul>
                        </div>
                    </section>

                    <!-- Section 4: Mechanism -->
                    <section class="content-section" id="mechanism">
                        <div class="section-header">
                            <div class="section-number">04</div>
                            <h2 class="section-title">
                                <span class="title-icon">‚öôÔ∏è</span>
                                Mechanism of Action
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Corticosteroids penetrate cells and bind to high affinity <strong>cytoplasmic receptors
                                    (GR)</strong>. The complex migrates to the nucleus, binds to <strong>Glucocorticoid
                                    Response Elements (GRE)</strong> on DNA, and regulates transcription of specific
                                genes (induction or repression). This process takes time (30-60 min lag), and effects
                                persist long after the drug is gone.</p>

                            <div class="callout callout--info">
                                <div class="callout-header">
                                    <span class="callout-icon">üí°</span>
                                    <h4 class="callout-title">Receptor Selectivity</h4>
                                </div>
                                <div class="callout-content">
                                    <p><strong>11$\beta$-HSD2 enzyme</strong> converts active Hydrocortisone to inactive
                                        Cortisone in mineralocorticoid target tissues (kidney), preventing GR activation
                                        of Mineralocorticoid Receptors. This explains why Hydrocortisone has weak
                                        mineralocorticoid activity despite high affinity for the receptor.</p>
                                </div>
                            </div>
                        </div>
                    </section>

                    <!-- Section 5: Preparations -->
                    <section class="content-section" id="preparations">
                        <div class="section-header">
                            <div class="section-number">05</div>
                            <h2 class="section-title">
                                <span class="title-icon">üíä</span>
                                Preparations & Relative Potency
                            </h2>
                        </div>

                        <div class="content-card">
                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <thead>
                                        <tr>
                                            <th>Compound</th>
                                            <th>Anti-inflammatory Potency</th>
                                            <th>Mineralocorticoid Potency</th>
                                            <th>Duration</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Hydrocortisone</strong></td>
                                            <td>1</td>
                                            <td>1</td>
                                            <td>Short</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Prednisolone</strong></td>
                                            <td>4</td>
                                            <td>0.8</td>
                                            <td>Intermediate</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Methylprednisolone</strong></td>
                                            <td>5</td>
                                            <td>0.5</td>
                                            <td>Intermediate</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Triamcinolone</strong></td>
                                            <td>5</td>
                                            <td>0</td>
                                            <td>Intermediate</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Dexamethasone</strong></td>
                                            <td>25</td>
                                            <td>0</td>
                                            <td>Long</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Betamethasone</strong></td>
                                            <td>25</td>
                                            <td>0</td>
                                            <td>Long</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Fludrocortisone</strong></td>
                                            <td>10</td>
                                            <td>150</td>
                                            <td>(Potent Mineralo)</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                            <p><strong>Deflazacort:</strong> A newer glucocorticoid with slightly less potency than
                                prednisolone but negligible mineralocorticoid activity and claimed to cause less growth
                                retardation.</p>
                        </div>
                    </section>

                    <!-- Section 6: Uses -->
                    <section class="content-section" id="uses">
                        <div class="section-header">
                            <div class="section-number">06</div>
                            <h2 class="section-title">
                                <span class="title-icon">üíâ</span>
                                Therapeutic Uses
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>A. Replacement Therapy</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><strong>Acute Adrenal Insufficiency (Addisonian Crisis):</strong>
                                    Emergency. Hydrocortisone 100 mg i.v. stat + infusion + saline/glucose.</li>
                                <li class="list-item"><strong>Chronic Adrenal Insufficiency (Addison's
                                        Disease):</strong> Oral Hydrocortisone + Fludrocortisone (if salt wasting
                                    persists).</li>
                                <li class="list-item"><strong>Congenital Adrenal Hyperplasia:</strong> Hydrocortisone
                                    (suppresses ACTH and androgen excess) + Fludrocortisone.</li>
                            </ul>

                            <h3>B. Pharmacotherapy (Non-endocrine)</h3>
                            <p>Palliative use in inflammatory/immune diseases.</p>
                            <ul class="enhanced-list">
                                <li class="list-item"><strong>Rheumatoid Arthritis:</strong> Adjuvant in severe cases.
                                    Intraarticular inj for single joint.</li>
                                <li class="list-item"><strong>Collagen Diseases:</strong> SLE, polyarteritis nodosa
                                    (life saving).</li>
                                <li class="list-item"><strong>Severe Allergic Reactions:</strong> Anaphylaxis (adjunct
                                    to Adrenaline), angioedema, serum sickness.</li>
                                <li class="list-item"><strong>Bronchial Asthma:</strong> Systemic for status
                                    asthmaticus; Inhaled for chronic control.</li>
                                <li class="list-item"><strong>Autoimmune Diseases:</strong> Hemolytic anemia, ITP,
                                    active chronic hepatitis.</li>
                                <li class="list-item"><strong>Skin Diseases:</strong> Pemphigus (life saving), eczema
                                    (topical).</li>
                                <li class="list-item"><strong>Eye Diseases:</strong> Uveitis, optic neuritis
                                    (contraindicated in viral keratitis).</li>
                                <li class="list-item"><strong>Malignancies:</strong> ALL, Hodgkin's lymphoma
                                    (lympholytic).</li>
                                <li class="list-item"><strong>Organ Transplantation:</strong> To prevent rejection.</li>
                                <li class="list-item"><strong>Cerebral Edema:</strong> Dexamethasone is preferred.</li>
                                <li class="list-item"><strong>Foetal Lung Maturation:</strong> Betamethasone to mother
                                    in threatened premature delivery.</li>
                            </ul>
                        </div>
                    </section>

                    <!-- Section 7: Adverse Effects -->
                    <section class="content-section" id="adverse-effects">
                        <div class="section-header">
                            <div class="section-number">07</div>
                            <h2 class="section-title">
                                <span class="title-icon">‚ö†Ô∏è</span>
                                Adverse Effects
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Extension of pharmacological actions with prolonged use.</p>
                            <div class="grid grid-2">
                                <div class="grid-item">
                                    <h4>Metabolic & Systemic</h4>
                                    <ul>
                                        <li><strong>Cushing's Habitus:</strong> Moon face, truncal obesity.</li>
                                        <li><strong>Hyperglycaemia:</strong> Precipitation of diabetes.</li>
                                        <li><strong>Muscle Wasting:</strong> Steroid myopathy.</li>
                                        <li><strong>Osteoporosis:</strong> Vertebral fractures.</li>
                                        <li><strong>Growth Retardation:</strong> In children.</li>
                                        <li><strong>Fluid Retention/HTN:</strong> (Mineralocorticoid effect).</li>
                                    </ul>
                                </div>
                                <div class="grid-item">
                                    <h4>Other Toxicities</h4>
                                    <ul>
                                        <li><strong>Susceptibility to Infection:</strong> TB flare-up, fungal
                                            infections.</li>
                                        <li><strong>Peptic Ulcer:</strong> Silent perforation.</li>
                                        <li><strong>Psychiatric:</strong> Euphoria, psychosis.</li>
                                        <li><strong>Eye:</strong> Posterior subcapsular cataract, Glaucoma.</li>
                                        <li><strong>Skin:</strong> Striae, bruising, atrophy.</li>
                                    </ul>
                                </div>
                            </div>
                        </div>
                    </section>

                    <!-- Section 8: Withdrawal -->
                    <section class="content-section" id="withdrawal">
                        <div class="section-header">
                            <div class="section-number">08</div>
                            <h2 class="section-title">
                                <span class="title-icon">üìâ</span>
                                HPA Suppression & Withdrawal
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Long term use suppresses the HPA axis causing adrenal atrophy. Abrupt withdrawal
                                precipitates <strong>Acute Adrenal Insufficiency</strong> (malaise, hypotension,
                                collapse).</p>
                            <div class="callout callout--warning">
                                <div class="callout-header">
                                    <span class="callout-icon">üõë</span>
                                    <h4 class="callout-title">Withdrawal Protocol</h4>
                                </div>
                                <div class="callout-content">
                                    <p>Withdrawal must be <strong>gradual</strong> over weeks/months. Patients on
                                        steroids need increased doses during stress (surgery, infection) to mimic the
                                        natural adrenal response.</p>
                                </div>
                            </div>
                            <p><strong>Minimizing Suppression:</strong> Use short acting drugs, lowest effective dose,
                                single morning dose, or alternate day therapy.</p>
                        </div>
                    </section>

                    <!-- Section 9: Inhibitors -->
                    <section class="content-section" id="inhibitors">
                        <div class="section-header">
                            <div class="section-number">09</div>
                            <h2 class="section-title">
                                <span class="title-icon">üö´</span>
                                Inhibitors & Antagonists
                            </h2>
                        </div>

                        <div class="content-card">
                            <ul class="enhanced-list">
                                <li class="list-item"><strong>Mifepristone:</strong> Glucocorticoid receptor antagonist
                                    (also antiprogestin). Used in inoperable Cushing's syndrome.</li>
                                <li class="list-item"><strong>Metyrapone:</strong> Inhibits 11$\beta$-hydroxylase
                                    (blocks cortisol synthesis). Diagnostic use.</li>
                                <li class="list-item"><strong>Ketoconazole:</strong> Antifungal; high doses inhibit
                                    steroid synthesis. Used in Cushing's syndrome.</li>
                                <li class="list-item"><strong>Aminoglutethimide:</strong> Inhibits conversion of
                                    cholesterol to pregnenolone (medical adrenalectomy).</li>
                            </ul>
                        </div>
                    </section>

                    <!-- Section 10: Case Study -->
                    <section class="content-section" id="case-study">
                        <div class="section-header">
                            <div class="section-number">10</div>
                            <h2 class="section-title">
                                <span class="title-icon">ü§î</span>
                                Problem Directed Study
                            </h2>
                        </div>

                        <div class="content-card">
                            <div class="callout callout--note">
                                <div class="callout-header">
                                    <span class="callout-icon">üìù</span>
                                    <h4 class="callout-title">Case 20.1</h4>
                                </div>
                                <div class="callout-content">
                                    <p>A 35-year female on Prednisolone (tapered to 10 mg/day) for inflammatory bowel
                                        disease meets with an accident and requires surgery.</p>
                                    <p><strong>(a) Additional Measure:</strong> The patient has likely
                                        <strong>suppression of the HPA axis</strong> due to chronic steroid therapy. She
                                        cannot mount a physiological cortisol response to the stress of surgery. She
                                        <strong>MUST</strong> receive supplemental corticosteroids (e.g., Hydrocortisone
                                        100 mg i.v.) during the perioperative period to prevent acute adrenal crisis and
                                        cardiovascular collapse.
                                    </p>
                                    <p><strong>(b) Postoperative Period:</strong> Prednisolone therapy should
                                        <strong>not</strong> be discontinued. It should be continued (initially
                                        parenteral, then oral) to prevent flare-up of bowel disease and because her
                                        adrenals are suppressed. The dose may be temporarily increased to cover the
                                        stress of recovery.
                                    </p>
                                </div>
                            </div>
                        </div>
                    </section>

                </main>

                <nav class="document-nav">
                    <div class="nav-container">
                        <a href="topic-20-insulin.html" class="nav-button nav-button--large nav-button--previous">
                            <div class="nav-label">Previous</div>
                            <div class="nav-title">Insulin & Oral Antidiabetics</div>
                        </a>

                        <div class="document-progress">
                            <div class="progress-indicator">
                                <span>21</span>
                                <span class="progress-separator">/</span>
                                <span>27</span>
                            </div>
                            <div class="progress-bar-container">
                                <div class="progress-bar-fill" style="width: 77%;"></div>
                            </div>
                            <div class="progress-label">Topic Progress</div>
                        </div>

                        <a href="topic-22-androgens.html" class="nav-button nav-button--large nav-button--next">
                            <div class="nav-label">Next</div>
                            <div class="nav-title">Androgens & ED Drugs</div>
                        </a>
                    </div>
                </nav>
            </article>
        </div>
    </div>

    <script src="../js/theme.js"></script>

    <script src="../js/navigation.js"></script>

    <script src="../js/interactions.js"></script>

</body>

</html>